Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2010 · third_quarter · Q3
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
Source: Senate LDA
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: 340B HEALTH · Firm: 340B HEALTH
S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to CMS regulations regarding physician administered drugs
HR 444; S 1239. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Definition Opposition to CMS
HR 444. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to CMS regulations regarding physician administered drugs
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Definition Opposition to CMS
HR 444. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
HR 444; S 1239; Health Care Reform Legislation Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
HR 444; S 1239; Health Care Reform Legislation Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
HR 444; S 1239; Health Care Reform Legislation Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
HR 444; S 1239. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Definition Opposition to CMS
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Definition Opposition to CMS
HR 444; S 1239; Health Care Reform Legislation Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
2009 · second_quarter · 2A
HR 444; S 1239; Health Care Reform Legislation Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · fourth_quarter · RA
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
2009 · third_quarter · Q3
HR 444; S 1239; HR 3200; S 1679. Extending the 340B Drug Discount to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Defintion Improving Medicaid rebimbursement to 340B covered entities
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2009 · third_quarter · RA
HR 444; S 1239. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Definition Opposition to CMS
HR 444; S 1239. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity Preserving current 340B Patient Definition Opposition to CMS
2009 · second_quarter · 2A
HR 444; S 1239; Health Care Reform Legislation Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · first_quarter · RA
HR 444. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to CMS regulations regarding physician administered drugs
HR 444. Extending 340B Pricing to the Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition Opposition to CMS regulations regarding physician administered drugs
2009 · first_quarter · Q1
HR 444. Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE